Connect Biopharma Funding: $190M Raised, IPO (2021)

Connect Biopharma is based in San Diego, California. It has raised $190M in total funding. Latest round: IPO.

Connect Biopharma funding overview

Connect Biopharma is based in San Diego, California. Connect Biopharma has raised $190M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is an IPO announced in March 2021. The round record for Connect Biopharma runs through 2021; nothing later has been disclosed. Investors on record include Lilly Asia Ventures, Qiming Venture Partners, 3W Capital. 3 distinct backers are named across the disclosed rounds.

Connect Biopharma at a glance

Total raised
$190M
Latest round
IPO
Latest round date
March 2021
Headquarters
San Diego, California
Notable investors
Lilly Asia Ventures, Qiming Venture Partners, 3W Capital

Frequently asked about Connect Biopharma funding

How much has Connect Biopharma raised?
Connect Biopharma has raised $190M in total disclosed funding across the rounds on record.
Who has invested in Connect Biopharma?
Lilly Asia Ventures, Qiming Venture Partners, 3W Capital are named among the investors backing Connect Biopharma.
What was the latest Connect Biopharma funding round?
The most recent disclosed round is an IPO, announced in March 2021.
Where is Connect Biopharma based?
Connect Biopharma is based in San Diego, California.
When did Connect Biopharma last raise?
The last disclosed Connect Biopharma round closed in March 2021 at IPO.

We update the Connect Biopharma record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in San Diego and their backers are listed below.

Companies related to Connect Biopharma (34)

Browse related funding lists (7)

Company funding database · Investor directory · Founder database · Mega-rounds 2026